Search for: "Astrazeneca LP" Results 141 - 156 of 156
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
2 Apr 2009, 3:56 am
AstraZeneca LP Addressing the oft-raised (recently) issue of whether pharmaceutical sales representative employees are subject to the Outside Sales exemption, the District Court answered the question in the affirmative and granted Defendant’s Motion for Summary Judgment on the issue. [read post]
8 Feb 2009, 9:35 pm
AstraZeneca Pharmaceuticals LP, No. 6:07-cv-15733-Orl-22DAB, slip op. [read post]
16 Jan 2009, 5:00 am
(IP finance) US: Medarex, Eurand and Alexion file actions against Director Dudas seeking revised patent term adjustment determinations (Patent Docs) US: Kubin panel questions motivation behind reversal in new Written Description Training Materials (Patent Docs) US: The obviousness of DNA - Federal Circuit heard oral argument for In re Kubin last week (Patent Docs)   Products Antara (Fenofibrate) – US: Oscient and Ethypharm file patent infringement suit against Lupin over Antara… [read post]
10 Nov 2008, 2:07 pm
AstraZeneca Pharmaceuticals LP, the court held that the complexity of having to prove the extent to which there actually was prescribing physician reliance - or none at all - or something in between - required dismissal of a third-party payer suit under Holmes v. [read post]
2 Oct 2008, 12:36 pm
Astrazeneca Pharmaceuticals, LP, 500 F.Supp.2d 736 (S.D. [read post]
23 Aug 2008, 1:23 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: DRM for streaming music dies a quiet death: (Electronic Frontier Foundation), (Techdirt) CAFC decides Apotex and Impax infringed AstraZeneca’s Prilosec patents: (Law360), (Patent Prospector), (Patent Docs), (GenericsWeb), CAFC upholds lower court’s decision finding USPTO was within its rights to subject a Cooper… [read post]
12 Jun 2008, 4:45 am
Omeprazole is the active ingredient in Prilosec ®, which is marketed by Plaintiffs-Appellants Astrazeneca, AB, Aktiebolaget Hassle, KBI-E, Inc., KBI, Inc., and Astrazeneca LP (Astrazeneca) for the treatment of gastric and duodenal ulcers, and which acts by inhibiting the production of gastric acid. [read post]
29 Feb 2008, 8:00 am
., claiming infringement of three patents covering its enlarged-prostate treatment, Avodart; Barr challenges GSK’s Avodart patent: (IP Law360), (GenericsWeb),Fosamax (Alendronate) – Courts in Netherlands and France both invalidate Merck Sharp & Dohme’s European patents for Alendronate: (IP Law360), (The IP Factor), (Generic Pharmaceuticals & IP), Hectorol – Genzyme Corp launches US patent suit against Pentech Pharmaceuticals to prevent it from… [read post]
22 Feb 2008, 6:00 pm
: (Patent Baristas),Vietnam : new developments in patent protection for medical uses: (Patent Docs),Wisconsin Alumni Research Foundation licenses stem cell patents to BioTime: (IPBiz)Pharma & Biotech - ProductsFloxin (Ofloxacin) –US Supreme Court declines Daiichi Sankyo’s request for appeal of CAFC decision reversing Daichii’s initial win in its ofloxacin patent infringement case against Apotex: (IP Law360),Galvus (Vildagliptin) – Indian patent granted… [read post]
8 Feb 2008, 7:00 pm
– Facebook’s contractual rights to users’ photos problematic: (Spicy IP)PharmaEuropean Commission probes pharmaceutical sector: (Philip Brooks),WHO Board sets course on IP, avian flu, tighter publication policy: (Intellectual Property Watch),India: The Competition Act, patents and over hyped drugs: (Part I - Spicy IP), (Part II – Spicy IP), (Part III – Spicy IP),Ignoring not the solution –… [read post]
3 Feb 2008, 9:47 pm
Astrazeneca Pharmaceuticals LP et al. 8:08-cv-00213; filed January 31, 2007 in the Middle District of Florida... [read post]
7 Jan 2008, 8:48 pm
Astrazeneca Pharmaceuticals LP et al. v. [read post]
1 Jul 2007, 9:07 pm
Astrazeneca Pharmaceuticals LP et. al. v. [read post]